Literature DB >> 9398628

Wortmannin, a specific inhibitor of phosphatidylinositol-3-kinase, enhances LPS-induced NO production from murine peritoneal macrophages.

Y C Park1, C H Lee, H S Kang, H T Chung, H D Kim.   

Abstract

To elucidate the role of phosphatidylinositol-3-kinase (PI3K) during macrophage activation, we examined the effects of wortmannin, a specific inhibitor of PI3K, on the induction of nitric oxide (NO) synthesis and tumor necrosis factor-alpha (TNF-alpha) secretion from lipopolysaccharide (LPS)-stimulated macrophages. Wortmannin had no effects on NO synthesis and TNF-alpha secretion by itself. Wortmannin markedly potentiated the LPS-induced NO production in a dose-dependent manner. Western blot analysis demonstrated that significantly increased levels of iNOS protein were expressed in LPS-stimulated macrophages treated with wortmannin, compared to those without LPS. Furthermore, enhancement of TNF-alpha secretion was observed in the initiation stage for activation of LPS-stimulated macrophages treated with wortmannin. These results suggest that PI3K plays an important role in transducing the signal that is involved in LPS-induced macrophage activation.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9398628     DOI: 10.1006/bbrc.1997.7722

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  22 in total

Review 1.  The biology of endotoxin.

Authors:  H Heine; E T Rietschel; A J Ulmer
Journal:  Mol Biotechnol       Date:  2001-11       Impact factor: 2.695

Review 2.  New players in TLR-mediated innate immunity: PI3K and small Rho GTPases.

Authors:  Monica Ruse; Ulla G Knaus
Journal:  Immunol Res       Date:  2006       Impact factor: 2.829

3.  TLR4/MyD88/PI3K interactions regulate TLR4 signaling.

Authors:  Michelle H W Laird; Sang Hoon Rhee; Darren J Perkins; Andrei E Medvedev; Wenji Piao; Matthew J Fenton; Stefanie N Vogel
Journal:  J Leukoc Biol       Date:  2009-03-16       Impact factor: 4.962

Review 4.  Crosstalk between insulin and Toll-like receptor signaling pathways in the central nervous system.

Authors:  Fatemeh Hemmati; Rasoul Ghasemi; Norlinah Mohamed Ibrahim; Leila Dargahi; Zahurin Mohamed; Azman Ali Raymond; Abolhassan Ahmadiani
Journal:  Mol Neurobiol       Date:  2014-01-25       Impact factor: 5.590

5.  TRAF6-NF-kappaB pathway is essential for interleukin-1-induced TLR2 expression and its functional response to TLR2 ligand in murine hepatocytes.

Authors:  Takayuki Matsumura; Takahiro Degawa; Takemasa Takii; Hidetoshi Hayashi; Takashi Okamoto; Jun-ichiro Inoue; Kikuo Onozaki
Journal:  Immunology       Date:  2003-05       Impact factor: 7.397

Review 6.  Regucalcin and cell regulation: role as a suppressor protein in signal transduction.

Authors:  Masayoshi Yamaguchi
Journal:  Mol Cell Biochem       Date:  2011-03-24       Impact factor: 3.396

7.  Differential roles of Toll-like receptors in the elicitation of proinflammatory responses by macrophages.

Authors:  B W Jones; K A Heldwein; T K Means; J J Saukkonen; M J Fenton
Journal:  Ann Rheum Dis       Date:  2001-11       Impact factor: 19.103

8.  Role of TLR-4 in liver macrophage and endothelial cell responsiveness during acute endotoxemia.

Authors:  Li C Chen; Ronald E Gordon; Jeffrey D Laskin; Debra L Laskin
Journal:  Exp Mol Pathol       Date:  2007-09-14       Impact factor: 3.362

9.  Regulation by insulin and insulin-like growth factor of 2-deoxyglucose uptake in primary ependymal cell cultures.

Authors:  Stephan Verleysdonk; Wolfgang Hirschner; John Wellard; Mirna Rapp; Maria de los Angeles Garcia; Francisco Nualart; Bernd Hamprecht
Journal:  Neurochem Res       Date:  2004-01       Impact factor: 3.996

10.  Genetic analysis of the role of the PI3K-Akt pathway in lipopolysaccharide-induced cytokine and tissue factor gene expression in monocytes/macrophages.

Authors:  James P Luyendyk; Gernot A Schabbauer; Michael Tencati; Todd Holscher; Rafal Pawlinski; Nigel Mackman
Journal:  J Immunol       Date:  2008-03-15       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.